Clinical efficacy of a localized cryostimulation device using metal conduction at -18°C (Niuk) in the management of musculoskeletal and neuropathic pain
Introduction
Local cryotherapy is widely used in functional rehabilitation to reduce pain, inflammation, and edema. Its mechanisms of action are primarily based on vasoconstriction, reduced cellular metabolism, and the inhibition of peripheral nerve conduction. However, conventional modalities (ice packs, gels, cryogenic sprays) present well-documented limitations: thermal instability, shallow depth of action, limited duration of effect, and a lack of associated mechanical stimulation.
The Niuk device was developed to overcome these limitations. It combines stable cryostimulation at -18°C obtained through a phase-change material (PCM), a 316L stainless steel conductive ball ensuring rapid and homogeneous thermal transfer, and continuous mechanical massage allowing for neurosensory modulation and transcutaneous diffusion of topical agents.
The objective of this study is to evaluate the clinical efficacy of the Niuk device, integrated into conventional physiotherapy protocols, in the management of musculoskeletal, inflammatory, and neuropathic pain, and to analyze its effects in comparison with common cryotherapy methods.
Methods
- Study type
Prospective, single-center, non-randomized observational study conducted in a physiotherapy practice.
- Population
The study includes 170 patients (87 women, 83 men), aged 43 to 84, presenting with pathologies divided into six categories: - inflammatory rheumatism (rheumatoid arthritis, ankylosing spondylitis, osteoarthritis), - peripheral neuropathies (post-chemotherapy, under methotrexate), - tendinopathies and enthesopathies, - compression syndromes (carpal tunnel), - post-surgical recovery (Dupuytren, post-arthrodesis spinal pain), - post-traumatic edema.
All patients received conventional rehabilitative care prior to the introduction of the Niuk device.
Device
The Niuk device includes: - a solid 316L stainless steel ball (diameters vary depending on the zone), - an internal polycarbonate compartment containing a PCM calibrated at -18°C, - a system for the controlled diffusion of cryo-compatible serum or oil.
Application protocol
The device, pre-cooled in a freezer (≥ 2 h), is applied to bare skin for 10 minutes per zone, using slow circular movements with light to moderate pressure. The frequency varies from 1 to 3 sessions per week.
The products used include: neutral oils, arnica oil, or CBD oil, depending on the clinical indication.
Evaluation criteria
-
Pain intensity (VAS 0–10),
-
duration of perceived relief,
-
evolution of functional mobility,
-
presence of edema or inflammatory signs,
-
sleep quality,
-
skin tolerance.
Results
- Overall results
The introduction of the Niuk device led to: - an average pain reduction from 7.8 ± 1.1 to 2.3 ± 1.0 (≈ –70%), - an average duration of relief of 3 to 6 days (vs. 24–48 h with conventional cryotherapy), - a reduction in joint stiffness in 75% of cases, - a reduction in edema and inflammatory signs in 88% of cases, - an improvement in sleep quality in 71% of patients.
No cutaneous or neurological adverse effects were observed.
- Subgroup analysis
The most marked effects were observed in patients suffering from inflammatory rheumatism and peripheral neuropathies, with relief starting from the first session and a cumulative effect over successive applications. Chronic tendinopathies showed rapid functional improvement, allowing for an early return to active exercises. Post-traumatic edema regressed significantly in less than 72 hours.
Discussion
The results show that the Niuk device provides an analgesic and anti-inflammatory effect superior to conventional local cryotherapy methods. This efficacy appears to be linked to the synergistic combination of several physiological mechanisms: inhibition of nerve conduction through deep cooling, vasomotor modulation with post-cold reflex vasodilation, stimulation of cutaneous and fascial mechanoreceptors (gate control theory), and tissue mechano-transduction.
The thermal stability of the PCM at -18°C allows for reproducible and controlled cryostimulation, unlike ice packs or sprays. The continuous spherical massage promotes myofascial relaxation and local sympathetic modulation. Finally, the transcutaneous diffusion of topical agents under cold could prolong the therapeutic effect beyond the cooling phase.
The main limitations of the study lie in the absence of a control group and randomization. However, the sample size, the consistency of the results, and their concordance with known physiological mechanisms reinforce the clinical validity of the observations.
Conclusion
This observational study suggests that the Niuk device constitutes a relevant therapeutic tool as an adjunct to conventional physiotherapy for the management of musculoskeletal and neuropathic pain. It allows for rapid, lasting, and well-tolerated relief, with significant functional improvement. Randomized controlled trials are now justified to confirm these results and define standardized usage protocols.